Location History:
- Saffron Walden, GB (2023)
- Lexington, MA (US) (2023)
Company Filing History:
Years Active: 2023
Title: K Mark Bushell: Innovator in Antibody Development
Introduction
K Mark Bushell is a prominent inventor based in Saffron Walden, GB. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. With a total of 2 patents, his work focuses on innovative therapeutic solutions.
Latest Patents
Bushell's latest patents include groundbreaking advancements in anti-TIGIT and anti-CD96 antibodies. The first patent provides multispecific molecules that specifically bind to CD96 and/or TIGIT, along with isolated antibodies that target human TIGIT. This patent also details pharmaceutical compositions that incorporate these molecules and antibodies, as well as methods for treating subjects using these innovative therapies. The second patent focuses on antibodies that specifically bind to human CD96 and antagonize its function. Similar to the first, it includes pharmaceutical compositions, nucleic acids, expression vectors, and methods for treatment.
Career Highlights
K Mark Bushell is currently associated with Agenus Inc., where he continues to push the boundaries of antibody research. His work has been instrumental in developing new therapeutic strategies that could potentially transform treatment options for various diseases.
Collaborations
Bushell collaborates with talented individuals such as Dhan Sidhartha Chand and Olga Ignatovich, contributing to a dynamic research environment that fosters innovation.
Conclusion
K Mark Bushell's contributions to antibody development exemplify the spirit of innovation in biotechnology. His patents reflect a commitment to advancing medical science and improving patient outcomes.